Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
61 - 70 of 155 results
- I Houbracken (Member)
- Anfien Huyghebaert (Member)
- Daniel Jacobs-Tulleneers-Thevissen (Member)
- Charlotte Janssens (Member)
- Mathias Janssens (Member)
- Hendrika Jaspers (Member)
- Shanthini Kannan (Member)
- Mina Kazemzadeh Dastjerd (Member)
- Elisabeth Knetemann (Member)
- Ron Kooijman (Member)
Projects
61 - 70 of 141
- Characterization of a novel cell population in the pancreas expressing the stem cell marker ΔNp63.From1 Nov 2020 → TodayFunding: FWO fellowships
- Creation of a dynamic intercellular liver communication platform to establish an anti-fibrotic combo-therapy for chronic liver diseases.From1 Nov 2020 → 31 Oct 2023Funding: FWO fellowships
- The impact of recurrent chromosomal abnormalities on growth advantage and differentiation capacity of human pluripotent stem cellsFrom1 Nov 2020 → TodayFunding: FWO fellowships
- Assessing the risk of SARS-CoV-2 infection for pregnancy and as possible cause of birth defectsFrom1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects
- Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)From1 Oct 2020 → 31 Dec 2023Funding: FWO fellowships
- SBO project with a primary economic finality aimed at the transfer to existing companies : iPSC-based parenchymal and sinusoidal liver cell mimics for DILI and NAFLD studies (iPSC-LiMic)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- Seahorse platform: the Agilent Seahorse Flux Analyser with integrated normalization systemFrom1 May 2020 → TodayFunding: Hercules - Small and Medium size research infrastructure
- Horizon 2020: I-MOVE-COVID-19 : Multidisciplinary European network for research, prevention and control of the COVID-19 PandemicFrom16 Mar 2020 → 15 Jun 2022Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- GEAR: Brussels Liver Research to Valorisation Alliance (B-Liver): Valorisation of VUB’s liver cell biology and toxicology expertise via a consortium focused on liver therapeutics, patient and consumer safety.From1 Jan 2020 → TodayFunding: IOF - technology concept exploration, IOF - mandates
- Sinusoidal cell communication in liver fibrosisFrom1 Jan 2020 → 31 Dec 2020Funding: FWO research grant KAN
Publications
1 - 10 of 1112
- PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF
Authors: Christos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, Leyun Pan, Caixia Cheng, Klaus Kopka, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss
Pages: 1343-1353 - Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
Authors: Mathias Witzens-Harig, Dirk Hose, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Ludmila Umansky, Anja Seckinger, Heinke Conrad, Bettina Brackertz, Thierry Rème, et al.
Pages: 4493-4503 - Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone
Authors: Katja C Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias K Mai, Mathias Haenel, Jan Duerig, Markus Munder, Hans-Walter Lindemann, Anja Seckinger, et al.
- DNA repair pathways in human multiple myeloma
Authors: Claire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder S Sahota, Thierry Rème, Jérôme Moreaux, Pascal Bourquard, Dirk Hose, Philippe Pasero, Angelos Constantinou, Bernard Klein
Pages: 2760-2773 - Daratumumab for systemic AL amyloidosis
Authors: Christoph R Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, et al.
Pages: 1517-1530 - Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma
Authors: Isabelle Herth, Mathias Witzens-Harig, Philipp Beckhove, Dirk Hose, Tobias Meissner, Brigitte Neuber, Melanie Engelhardt, Jürgen Haas, Kai Neben, Anthony D Ho, et al.
Pages: 231-240 - The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Authors: P Y Liu, N Xu, A Malyukova, Christopher J Scarlett, Y T Sun, X D Zhang, D Ling, S-P Su, Claudia Benitez-Nelson, David K Chang, et al.
Pages: 503-514 - Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
Authors: Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans J Salwender, Igor W Blau, Katja Weisel, et al.
Pages: e116-e119 - Hitting the target without pulling the trigger.
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 4-6 - Combinatorial strategies for the induction of immunogenic cell death.
Authors: L Bezu, LC Gomes-de-Silva, Heleen Dewitte, Karine Breckpot, J Fucikova, Radek Spisek, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer